comparemela.com

Latest Breaking News On - Tango therapeutics - Page 1 : comparemela.com

Insider Selling: Tango Therapeutics, Inc. (NASDAQ:TNGX) Insider Sells 63,000 Shares of Stock

Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) insider Mva Investors, Llc sold 63,000 shares of the stock in a transaction that occurred on Thursday, June 6th. The stock was sold at an average price of $7.24, for a total transaction of $456,120.00. Following the completion of the transaction, the insider now owns 420,524 shares […]

Piper-sandler
Clear-harbor-asset-management
Pricet-rowe-associates-inc
Sg-americas-securities
Mva-investors-llc
Tango-therapeutics-inc
Barclays
Cantor-fitzgerald
Nasdaq
Exchange-traded-concepts
Tango-therapeutics
Get-free-report

Tango Therapeutics, Inc. (NASDAQ:TNGX) Insider Mva Investors, Llc Sells 63,000 Shares

Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) insider Mva Investors, Llc sold 63,000 shares of Tango Therapeutics stock in a transaction that occurred on Thursday, June 6th. The stock was sold at an average price of $7.24, for a total value of $456,120.00. Following the completion of the transaction, the insider now owns 420,524 […]

China
Piper-sandler
Barclays
Cantor-fitzgerald
Nasdaq
Pricet-rowe-associates-inc
China-universal-asset-management-co
Mva-investors-llc
Paloma-partners-management-co
Tango-therapeutics-company-profile
Tango-therapeutics-inc
Tango-therapeutics

Q2 2024 EPS Estimates for Tango Therapeutics, Inc. (NASDAQ:TNGX) Cut by Analyst

Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) – Stock analysts at HC Wainwright lowered their Q2 2024 earnings per share estimates for Tango Therapeutics in a research note issued to investors on Tuesday, May 28th. HC Wainwright analyst R. Burns now forecasts that the company will post earnings of ($0.36) per share for the quarter, […]

Piper-sandler
Boxer-capital
Tango-therapeutics-company-profile
Tango-therapeutics-inc
Nasdaq
Mva-investors-llc
Deerfield-management-companylp-series
Cantor-fitzgerald
Artal-group
Securities-exchange-commission
Barclays
Tango-therapeutics

HC Wainwright Cuts Tango Therapeutics (NASDAQ:TNGX) Price Target to $13.00

Tango Therapeutics (NASDAQ:TNGX – Free Report) had its price target cut by HC Wainwright from $16.00 to $13.00 in a research report sent to investors on Tuesday, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Tango Therapeutics’ Q2 2024 earnings at ($0.36) EPS, Q3 2024 earnings […]

China
Piper-sandler
Barclays
China-universal-asset-management-co
Tango-therapeutics-inc
Pricet-rowe-associates-inc
Mva-investors-llc
Cantor-fitzgerald
Tango-therapeutics-company-profile
Securities-exchange-commission
Paloma-partners-management-co
Tango-therapeutics

HC Wainwright Trims Tango Therapeutics (NASDAQ:TNGX) Target Price to $13.00

Tango Therapeutics (NASDAQ:TNGX – Free Report) had its price target trimmed by HC Wainwright from $16.00 to $13.00 in a report released on Tuesday morning, Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Tango Therapeutics’ Q2 2024 earnings at ($0.36) EPS, Q3 2024 earnings at […]

China
Piper-sandler
Cantor-fitzgerald
Paloma-partners-management-co
Barclays
China-universal-asset-management-co
Mva-investors-llc
Tango-therapeutics-inc
Pricet-rowe-associates-inc
Tango-therapeutics
Free-report
Get-free-report

vimarsana © 2020. All Rights Reserved.